Jiangsu Heli Pharmaceutical Co signs a deal with the Nantong Economic and Technological Development Area on Feb 26. [Photo provided to NETDA]
Representatives of Jiangsu Heli Pharmaceutical Co on Feb 26 signed an agreement to establish a medical headquarters in the Nantong Economic and Technological Development Area (NETDA), Jiangsu province.
The 200-million-yuan ($27.78 million) facility will specialize in the research, development, and sale of a range of products, including oncology diagnostics, Parkinson's disease diagnostics, and oncology therapeutic injections.
The project is expected to generate sales of 400 million yuan and contribute 30 million yuan in tax revenue.
This significant investment is poised to further enhance the high-quality development of the pharmaceutical and healthcare industry in NETDA.